Chk1 deficiency in the mouse small intestine results in p53-independent crypt death and subsequent intestinal...

Area of Science:

• Cell Biology
• Molecular Biology
• Genetics

Background:

• Checkpoint kinase 1 (Chk1) is crucial for cell cycle arrest in response to DNA damage.
• Chk1 inhibitors are investigated as cancer therapeutics to sensitize tumor cells.
• Understanding Chk1's in vivo role in adult tissues is essential for therapeutic development.

Purpose of the Study:

• To investigate the in vivo consequences of inducible Chk1 deletion in adult mouse somatic epithelial cells.
• To determine the impact of Chk1 loss on liver and small intestine homeostasis and cellular responses.
• To assess the potential for organ-level compensation following Chk1-deficient cell lethality.

Main Methods:

• Generation of a Cre-Lox-based inducible mouse model for Chk1 deletion.
• Inducible deletion of Chk1 in somatic epithelial cells of adult mice, specifically targeting the liver and small intestine.
• Analysis of DNA damage, apoptosis, cell cycle progression, and tissue regeneration following Chk1 ablation.

Main Results:

• Inducible Chk1 deletion in the liver was well-tolerated with no observable phenotype.
• Loss of Chk1 in the small intestine induced immediate DNA damage and p53-independent apoptosis, leading to crypt death.
• The small intestine demonstrated remarkable compensatory capacity through repopulation by Chk1-proficient cells, maintaining organ integrity.

Conclusions:

• Chk1 deficiency is intrinsically lethal to individual cells.
• The adult mouse intestine can tolerate Chk1-deficient cell lethality at the organ level through compensatory proliferation.
• These findings highlight the complex interplay between cell-intrinsic responses and organ-level resilience in the face of DNA damage response disruption.